Milestone Scientific Statistics
Share Statistics
Milestone Scientific has 77.89M shares outstanding. The number of shares has increased by 1.94% in one year.
| Shares Outstanding | 77.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.08% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 49.10M |
| Failed to Deliver (FTD) Shares | 4.02K |
| FTD / Avg. Volume | 2.86% |
Short Selling Information
The latest short interest is 113.24K, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 113.24K |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.23% |
| Short Ratio (days to cover) | 1.65 |
Valuation Ratios
The PE ratio is -7.25 and the forward PE ratio is -17.5.
| PE Ratio | -7.25 |
| Forward PE | -17.5 |
| PS Ratio | 5.11 |
| Forward PS | 5.5 |
| PB Ratio | 6.27 |
| P/FCF Ratio | -9.42 |
| PEG Ratio | n/a |
Enterprise Valuation
Milestone Scientific Inc. has an Enterprise Value (EV) of 47.63M.
| EV / Earnings | -6.87 |
| EV / Sales | 4.85 |
| EV / EBITDA | -6.85 |
| EV / EBIT | -6.7 |
| EV / FCF | -8.93 |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.51 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 1.4 |
| Cash Flow / Debt | -46.85 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.86% and return on capital (ROIC) is -82.42%.
| Return on Equity (ROE) | -0.86% |
| Return on Assets (ROA) | -0.61% |
| Return on Capital (ROIC) | -82.42% |
| Revenue Per Employee | 578.08K |
| Profits Per Employee | -407.59K |
| Employee Count | 17 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 1.15 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 38.17% in the last 52 weeks. The beta is 1.08, so Milestone Scientific 's price volatility has been higher than the market average.
| Beta | 1.08 |
| 52-Week Price Change | 38.17% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 0.8 |
| Relative Strength Index (RSI) | 49.63 |
| Average Volume (20 Days) | 140.29K |
Income Statement
In the last 12 months, Milestone Scientific had revenue of $9.83M and earned -$6.93M in profits. Earnings per share was $-0.1.
| Revenue | 9.83M |
| Gross Profit | 6.79M |
| Operating Income | -7.11M |
| Net Income | -6.93M |
| EBITDA | -6.96M |
| EBIT | -7.11M |
| Earnings Per Share (EPS) | -0.1 |
Balance Sheet
The company has $2.98M in cash and $395.98K in debt, giving a net cash position of $2.58M.
| Cash & Cash Equivalents | 2.98M |
| Total Debt | 395.98K |
| Net Cash | 2.58M |
| Retained Earnings | -123.34M |
| Total Assets | 11.17M |
| Working Capital | 6.94M |
Cash Flow
In the last 12 months, operating cash flow was -$5.33M and capital expenditures -$4.88K, giving a free cash flow of -$5.33M.
| Operating Cash Flow | -5.33M |
| Capital Expenditures | -4.88K |
| Free Cash Flow | -5.33M |
| FCF Per Share | -0.07 |
Margins
Gross margin is 69.12%, with operating and profit margins of -72.31% and -70.51%.
| Gross Margin | 69.12% |
| Operating Margin | -72.31% |
| Pretax Margin | -71.04% |
| Profit Margin | -70.51% |
| EBITDA Margin | -70.78% |
| EBIT Margin | -72.31% |
| FCF Margin | -54.25% |
Dividends & Yields
MLSS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -12.5% |
| FCF Yield | -8.5% |
Analyst Forecast
Currently there are no analyst rating for MLSS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jan 14, 2004. It was a backward split with a ratio of 1:3.
| Last Split Date | Jan 14, 2004 |
| Split Type | backward |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | -6.18 |
| Piotroski F-Score | 2 |